MARKSANS PHARMA
|
The Current P/S Ratio of MARKSANS PHARMA is 2.80.
| Share Price | ₹169.0 | Jan 21,2026 |
| Market Cap | ₹7,656.8 Cr | |
| Sales-TTM | ₹2,730.7 Cr | TTM-Consolidated Results |
| Price/Sales | 2.80x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of MARKSANS PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹7,656.8 Cr] as on Jan 21,2026
(/) Sales [ ₹2,730.7 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.80x ]
Thus, for MARKSANS PHARMA , the investors are currently willing to pay '2.80 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of MARKSANS PHARMA !
The chart below summarizes the trend in P/S Ratio of MARKSANS PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of MARKSANS PHARMA
PS Ratio Performance Analysis for MARKSANS PHARMA
- MARKSANS PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.29x.
- MARKSANS PHARMA 's operated at median p/e ratio of 1.72x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MARKSANS PHARMA 's p/e ratio peaked in Mar2025 at 3.84x.
- MARKSANS PHARMA 's p/e ratio hit its five-year low in Mar2022 of 1.25x.
How does MARKSANS PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| MARKSANS PHARMA | 2,730.7 | 2.80 | 7,656.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.04 | 386,905.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 15.89 | 159,357.0 |
| CIPLA LTD | 28,349.6 | 3.90 | 110,628.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 11.00 | 134,788.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 2.78 | 96,441.5 |
| MANKIND PHARMA LTD | 13,576.9 | 6.38 | 86,682.9 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.60 | 88,156.2 |
| LUPIN LTD | 24,750.7 | 3.95 | 97,727.5 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.00 | 65,145.6 |
| ABBOTT INDIA LTD | 6,714.4 | 8.74 | 58,658.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs MARKSANS PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.00x |
| Max industry PS | 15.89x |
| Median industry PS | 3.95x |
| Average industry PS | 6.19x |
You may also like the below Video Courses